GCT delivered exceptional 65% revenue growth to $1.2B while maintaining strong profitability and cash generation, though share count declined and market valuation dropped significantly.
The company demonstrates robust operational execution with revenue scaling faster than costs, evidenced by 21% operating cash flow growth and 46% cash increase. However, the 38% decline in market value (from $30.42 to $19.78 per share) despite strong fundamentals suggests potential market mispricing or investor concerns about sustainability of growth rates.
GCT shows impressive growth across key metrics with revenue surging 65% to $1.2B while operating cash flow grew 21% to $190.7M, indicating strong operational leverage. The balance sheet strengthened substantially with cash rising 46% to $379.8M and stockholders' equity increasing 20% to $485.8M, while the company reduced capital expenditures by 49%. Despite doubled interest expense, the overall financial picture signals a rapidly scaling, cash-generative business with improving efficiency metrics.
Interest expense surged 118.3% — significant debt increase or rising rates materially impacting earnings.
Strong top-line growth of 65% — accelerating demand or successful expansion into new markets.
Capex reduced 49.3% — investment cycle winding down or capital discipline; may improve near-term free cash flow.
Cash position surged 46.2% — strong cash generation or capital raise providing significant financial cushion.
Current liabilities rose 29.5% — increased short-term obligations, watch current ratio.
Current assets grew 26.1% — improving short-term liquidity or inventory/receivables build.
Operating cash flow grew 20.6% — strong conversion of earnings to cash, healthy business fundamentals.
Equity base grew 19.9% — retained earnings accumulation or equity issuance strengthening the balance sheet.
Receivables grew 15.1% — monitor days sales outstanding for collection efficiency.
Asset base grew 12.3% — expansion through organic growth, acquisitions, or capital deployment.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →